AI Insight
Researchers are exploring the potential of ivermectin, an antiparasitic drug, as a tool to reduce malaria transmission. The approach involves treating human populations with ivermectin so that mosquitoes feeding on treated individuals ingest the drug and die before they can transmit the malaria parasite. Quantitative modeling work, led by scientists including Virginia Tech researcher Cassidy Rist and physician Carlos Chaccour of the University of Navarra, aims to estimate the epidemiological impact of this strategy.
Why it matters
If validated through trials, ivermectin-based strategies could offer a supplementary tool against malaria in regions where conventional mosquito control methods are insufficient. This approach could be particularly valuable given the growing resistance of mosquitoes to standard insecticides.
When a stranger from Spain called Cassidy Rist in her first months at Virginia Tech, she almost didn’t take the meeting. The caller was Carlos Chaccour, a physician at the University of Navarra who worked on global health and tropical diseases. He told her he was working on ivermectin for malaria.
Source: Running the numbers shows ivermectin could help beat malaria